Skip to Main Content
USF Health Morsani College of Medicine Research video

Shaping the future of health

Laura Bohn smiling wearing a USF Health branded medical white coat with a green blouse

The Morsani College of Medicine has active research programs in basic, translational, and clinical sciences. Research is carried out in Departments, Institutes, Centers and at our Veterans Hospitals and our primary teaching facility, Tampa General Hospital. In addition, there are rich collaborations with the Colleges of Public Health, Nursing and Pharmacy as well as the USF College of Arts and Sciences.

Our goal is to pursue new knowledge in the biomedical sciences, clinical sciences, and healthcare delivery, relevant to human health and disease. Please explore our research initiatives using the tabs above. The resources tab provides information for current faculty to facilitate research efforts.

Laura M. Bohn, PhD 
Senior Associate Vice President of Research, USF Health
Vice Dean for Research, Morsani College of Medicine
Professor, Molecular Pharmacology & Physiology
Email: lbohn@usf.edu

Research Day

USF Health Morsani College of Medicine logo; USF Health Research Day 2027 March 5

Celebrating health science research

Our annual celebration of groundbreaking research and scientific excellence continues - March 5, 2027.

The registration portal will be open soon, please check back.

A look back at Research Day 2026

Despite their different questions and disciplines, they shared a common goal: advancing the science that shapes how people live and receive care.

Those conversations, and hundreds more like them, filled the USF Marshall Student Center during the 36th annual USF Health Research Day, the university’s largest celebration of health sciences research.

Read more about USF Health Research Day 2026.

Health Science Innovation

Isolated clival Langerhans cell histiocytosis in a pediatric patient: systematic review and illustrative case report

Isolated clival Langerhans cell histiocytosis in a pediatric patient: systematic review and illustrative case report

CONCLUSION: Isolated clival LCH is an exceptionally rare presentation that can radiologically mimic aggressive skull base neoplasms. Histopathological confirmation is essential. Early recognition and appropriate multidisciplinary management are associated with favorable outcomes.

Network of interactions between the tumor necrosis factor superfamily members and small S100 proteins

Network of interactions between the tumor necrosis factor superfamily members and small S100 proteins

Tumor Necrosis Factor Superfamily (TNFSF) comprises 20 members of membrane/soluble signaling proteins regulating cell survival, cell proliferation/differentiation, and innate/adaptive immunity. Targeting signaling of TNFSF members is used clinically to treat several autoimmune and oncological diseases, and bone loss. They and their cognate receptors are in clinical trials as targets for treatment of autoimmune, inflammatory, oncological and other diseases. Recently, some representatives of S100.

Gene expression and brain pathology at the early stages of bilateral chronic cerebral hypoperfusion in the female mouse brain

Gene expression and brain pathology at the early stages of bilateral chronic cerebral hypoperfusion in the female mouse brain

Chronic cerebral hypoperfusion (CCH) is a major risk factor for neurodegenerative diseases, including vascular dementia (VD). It is well documented that sex differences account for variability in progression and outcomes in cerebrovascular pathophysiology and dementia risk. Despite extensive study of VD, most mechanistic and preclinical work has been conducted in male animals, leaving the molecular and cellular consequences of CCH in the female brain largely unexplored. To address this critical.